HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kenichi Tanaka Axel Haverich Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rahe-Meyer, N. Articles by Pichlmaier, M. Search for Related Content PubMed Articles by Rahe-Meyer, N. Articles by Pichlmaier, M.

J Thorac Cardiovasc Surg 2009;138:694-702
© 2009 The American Association for Thoracic Surgery

Perioperative Management

Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery

^a Department of Anesthesiology, Hannover Medical School, Hannover, Germany
^b Department of Anesthesiology, Emory University, Atlanta, Ga
^c Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany

Received for publication July 28, 2008; revisions received October 28, 2008; accepted for publication November 22, 2008.

^_* Address for reprints: Niels Rahe-Meyer, MD, MSc, PhD, Hannover Medical School, Department of Anaesthesiology, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. (Email: Rahe-Meyer.Niels{at}MH-Hannover.de).

Objective: Thoracoabdominal aortic aneurysm operations are associated with extensive blood loss and high requirements for allogeneic blood product transfusion. We assessed the efficacy of intraoperative post–cardiopulmonary bypass administration of fibrinogen concentrate in elective thoracoabdominal aortic aneurysm surgery.

Methods: In a retrospective group (group A, n = 12) of patients undergoing elective thoracoabdominal aortic aneurysm surgery, clinically relevant diffuse bleeding after weaning from cardiopulmonary bypass was treated with allogeneic blood products (platelet concentrates, followed by fresh frozen plasma) according to a predetermined algorithm.

In a prospective group (group F, n = 6) a first therapy step with fibrinogen concentrate was added to the algorithm. The dose of fibrinogen concentrate was estimated by using thromboelastometric data (ROTEM FIBTEM). Before each step of hemostatic therapy, blood loss in the range of 60 to 250 g per 5 minutes was confirmed.

Results: In group F, administration of 7.8 ± 2.7 g of fibrinogen concentrate established hemostasis, completely avoiding intraoperative transfusion of fresh frozen plasma and platelet concentrates. Transfusion of blood products after cardiopulmonary bypass and during the 24 hours after surgical intervention was markedly lower in group F than in group A (2.5 vs 16.4 units; 4/6 patients in group F required no transfusion of blood products), as was 24-hour drainage volume (449 vs 1092 mL). Fibrinogen plasma levels, standard coagulation parameters, and hemoglobin and hematocrit values were comparable between the 2 groups on the first postoperative day.

Conclusions: FIBTEM-guided post–cardiopulmonary bypass administration of fibrinogen concentrate resulted in improved intraoperative management of coagulopathic bleeding in thoracoabdominal aortic aneurysm operations and reduced transfusion and 24-hour drainage volume.

This article has been cited by other articles:

				J. H. Levy, F. Szlam, K. A. Tanaka, and R. M. Sniecienski Review Article: Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding Anesth. Analg., February 1, 2012; 114(2): 261 - 274. [Abstract] [Full Text] [PDF]

				M. Karlsson, L. Ternstrom, M. Hyllner, F. Baghaei, S. Skrtic, and A. Jeppsson Prophylactic Fibrinogen Infusion in Cardiac Surgery Patients: Effects on Biomarkers of Coagulation, Fibrinolysis, and Platelet Function Clinical and Applied Thrombosis/Hemostasis, August 1, 2011; 17(4): 396 - 404. [Abstract] [PDF]

				M. C. Wesley, K. Yuki, D. G. Daaboul, and J. A. DiNardo Blood Utilization in Neonates and Infants Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass World Journal for Pediatric and Congenital Heart Surgery, July 1, 2011; 2(3): 382 - 392. [Abstract] [Full Text] [PDF]

				M. Takata, G. Watanabe, H. Ohtake, T. Ushijima, S. Yamaguchi, Y. Kikuchi, and Y. Yamamoto Automatic aortic anastomosis with an innovative computer-controlled circular stapler for surgical treatment of aortic aneurysm J. Thorac. Cardiovasc. Surg., May 1, 2011; 141(5): 1265 - 1269. [Abstract] [Full Text] [PDF]

				J. B. Williams, B. Phillips-Bute, S. D. Bhattacharya, A. A. Shah, N. D. Andersen, B. Altintas, B. Lima, P. K. Smith, G. C. Hughes, and I. J. Welsby Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., May 1, 2011; 141(5): 1283 - 1288. [Abstract] [Full Text] [PDF]

				C. F. Weber, C. Jambor, C. Strasser, A. Moritz, N. Papadopoulos, K. Zacharowski, and D. Meininger Normovolemic modified ultrafiltration is associated with better preserved platelet function and less postoperative blood loss in patients undergoing complex cardiac surgery: A randomized and controlled study J. Thorac. Cardiovasc. Surg., May 1, 2011; 141(5): 1298 - 1304. [Abstract] [Full Text] [PDF]

				D. Fries and W. Z. Martini Role of fibrinogen in trauma-induced coagulopathy Br. J. Anaesth., August 1, 2010; 105(2): 116 - 121. [Abstract] [Full Text] [PDF]

				C. Solomon, U. Pichlmaier, H. Schoechl, C. Hagl, K. Raymondos, D. Scheinichen, W. Koppert, and N. Rahe-Meyer Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery Br. J. Anaesth., May 1, 2010; 104(5): 555 - 562. [Abstract] [Full Text] [PDF]